Loading...
Survey of the use of warfarin and the newer anticoagulant dabigatran in patients with atrial fibrillation
BACKGROUND: Oral dabigatran was recently approved as an alternative to warfarin for prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. Unlike warfarin, dabigatran has a fixed dosage and few drug interactions, and does not require anticoagulation monitoring o...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3923612/ https://ncbi.nlm.nih.gov/pubmed/24532967 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S56187 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|